iShares Evolved U.S. Innovative Healthcare ETF
IEIH
IEIH was delisted on the 22nd of August, 2022.
14 hedge funds and large institutions have $6.68M invested in iShares Evolved U.S. Innovative Healthcare ETF in 2020 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 3 reducing their positions, and 3 closing their positions.
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
22% more capital invested
Capital invested by funds: $5.48M → $6.68M (+$1.2M)
17% more funds holding
Funds holding: 12 → 14 (+2)
0% more repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Truist Financial
Charlotte,
North Carolina
|
+$1.56M |
| 2 |
Morgan Stanley
New York
|
+$55.1K |
| 3 |
PIMG
Patriot Investment Management Group
Knoxville,
Tennessee
|
+$51.2K |
| 4 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$47.4K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$9.53K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TRCT
Tower Research Capital (TRC)
New York
|
-$965K |
| 2 |
DAS
Dynamic Advisor Solutions
Phoenix,
Arizona
|
-$18.9K |
| 3 |
SWM
Strategic Wealth Management
Kirkland,
Washington
|
-$12.5K |
| 4 |
CAPTRUST Financial Advisors
Raleigh,
North Carolina
|
-$11K |
| 5 |
Osaic Holdings
Scottsdale,
Arizona
|
-$8.06K |
IEIH Hedge Fund Activity: Q4 2020 in Review
14 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in iShares Evolved U.S. Innovative Healthcare ETF (IEIH) for Q4 2020, worth a combined $6.68M — up 22% from $5.48M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new IEIH positions and 3 closed out — a net gain of 2 holders — while 3 added to existing stakes and 3 trimmed.
The largest buyer was Truist Financial, opening a new position worth an estimated $1.56M. The largest seller was Tower Research Capital (TRC), exiting entirely with an estimated $965K sold.
- 14 institutional investors held iShares Evolved U.S. Innovative Healthcare ETF (IEIH) as of Q4 2020, up from 12 in Q3 2020.
- Funds reported $6.68M of iShares Evolved U.S. Innovative Healthcare ETF stock for Q4 2020, up 22% quarter-over-quarter.
- 5 funds opened new iShares Evolved U.S. Innovative Healthcare ETF positions in Q4 2020 and 3 closed out, a net change of +2 holders.
- The largest iShares Evolved U.S. Innovative Healthcare ETF buyer in Q4 2020 was Truist Financial, an estimated $1.56M added.
- The largest iShares Evolved U.S. Innovative Healthcare ETF seller in Q4 2020 was Tower Research Capital (TRC), an estimated $965K sold.
Based on aggregated 13F filings for Q4 2020.